Minapharm PharmaceuticalsCAI:MIPH -0.27%41 Days Inventory is 122.06 as of Dec. 2025, which is 6% below its 10-year median of 129.46. GuruFocus rates CAI:MIPH with a GF Score™ of 41/100 and a GF Value™ of E£362.31 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 923 Drug Manufacturers companies, Minapharm Pharmaceuticals ranks better than 72.37% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Minapharm Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.75.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Minapharm Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.88.
Minapharm Pharmaceuticals (CAI:MIPH) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Minapharm Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Minapharm Pharmaceuticals's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Minapharm Pharmaceuticals Days Inventory Related Terms
Minapharm Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAI:MIPH vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Minapharm Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Minapharm Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minapharm Pharmaceuticals (CAI:MIPH) has a Days Inventory of 122.06 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Minapharm Pharmaceuticals and its competitors. This is near median its historical median of 129.46. Over the past decade, Minapharm Pharmaceuticals' Days Inventory has ranged from 113.97 to 134.07. According to the industry distribution chart, Minapharm Pharmaceuticals ranks #255 out of 923 companies in the Drug Manufacturers industry, placing it in the top 27.6%.
Is Minapharm Pharmaceuticals' Days Inventory too high?
Minapharm Pharmaceuticals' current Days Inventory of 122.06 is near median its 10-year median of 129.46. Over the past 10 years, this metric has ranged from a low of 113.97 to a high of 134.07. The Drug Manufacturers industry median Days Inventory is 164.48. Minapharm Pharmaceuticals' value of 122.06 is 25.8% below this industry median. Based on the distribution chart, Minapharm Pharmaceuticals ranks #255 out of 923 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Minapharm Pharmaceuticals has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Minapharm Pharmaceuticals' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Minapharm Pharmaceuticals ranks #255 out of 923 companies for Days Inventory. This puts Minapharm Pharmaceuticals in the upper half of its industry. The industry median Days Inventory is 164.48. Minapharm Pharmaceuticals' value of 122.06 is 25.8% below this benchmark. Historically, Minapharm Pharmaceuticals' own Days Inventory has ranged from 113.97 to 134.07 over the past decade. While the company's 10-year median is 129.46 vs. the industry median of 164.48, Minapharm Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Minapharm Pharmaceuticals's current Days Inventory of 122.06 is 25.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Minapharm Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Minapharm Pharmaceuticals's current Days Inventory is 122.06, which is near median its own 10-year median of 129.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minapharm Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Minapharm Pharmaceuticals (CAI:MIPH) is currently considered Significantly Overvalued. The stock's GF Value™ is E£362.31, compared to a current price of E£698.08 — trading 92.7% above its estimated fair value. The current Days Inventory is 122.06, which is near median its 10-year median of 129.46 and 25.8% below the Drug Manufacturers industry median of 164.48. Minapharm Pharmaceuticals' overall GF Score™ is 41/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Minapharm Pharmaceuticals (CAI:MIPH), the current Days Inventory is 122.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Minapharm Pharmaceuticals (CAI:MIPH) Overvalued in 2026?
Based on GuruFocus' analysis, Minapharm Pharmaceuticals stock appears to be overvalued.
The current stock price of E£698.08 is trading 92.7% above its estimated GF Value™ of E£362.31.
GuruFocus considers Minapharm Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for CAI:MIPH:
Days Inventory: 122.06 (near median its 10-year median of 129.46)
GF Value™: E£362.31 vs. price of E£698.08 (92.7% above fair value)
Industry Position: 25.8% below the Drug Manufacturers median (#255 of 923)
No single metric tells the full story. See the CAI:MIPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.
41GF Score
Get the complete analysis for CAI:MIPH
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:MIPH has been successfully added to your 
